Breaking News, Financial News

Cryoport Reports Record Revenue

Revenue from commercial therapies increased 295% to $8.3 million in 2019

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cryoport 1Q Revenues: $9.2 million (+62%) 1Q Loss: $947,539 (loss of $2.3 million 1Q19) FY Revenues: $33.9 million (+73%) FY Loss: $18.3 million (loss of $9.6 million FY19) Comments: Revenue from commercial therapies increased 295% year over year to $8.3 million. Cryoport now supports 436 clinical trials in Regenerative Medicine market. The number of trials in Phase III grew to 56, compared with 47 as of December 31, 2018. Bioservices revenue was $1.3 million and $3.0 million...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters